Elizabeth Barrett Net Worth & Insider Trades
Elizabeth Barrett - Chief Executive Officer, Urogen Pharma Ltd
What is Elizabeth Barrett's Net Worth?
The current estimated net worth of Urogen Pharma Ltd's Chief Executive Officer, Elizabeth Barrett, is estimated to be about $1.42M . Elizabeth Barrett owns about 308,358 units of Urogen Pharma Ltd common stock. In the last 4 years at Urogen Pharma Ltd, Elizabeth Barrett has sold an estimated value of $551.84K worth.
What is Elizabeth Barrett's Past Insider Trading?
Elizabeth Barrett's largest purchase order was 7,530 units , worth over $210.84K on November 22, 2019. Elizabeth Barrett's largest sale order was 46,968 units , worth over $429.76K on January 7, 2022. In total, Elizabeth Barrett has made about 14 transactions over 4 years of their time at Urogen Pharma Ltd. Elizabeth Barrett usually trades in February, with the busiest year in 2020. The most recent transaction was a sale order of 8,195 units , worth over $62.12K on February 2, 2022.
Elizabeth Barrett
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Elizabeth Barrett's Salary in 2020?
As Chief Executive Officer of Urogen Pharma Ltd, Elizabeth Barrett has a total base salary of $636,987 . Elizabeth Barrett received compensation valued at about $2,466,667 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of a bonus of $0 , stock awards of $441,150 , option awards of $876,164 , other earnings, plans or compensations of $468,650 , and other compensation of $43,716 .
What is Elizabeth Barrett's' Mailing Address?
- Mailing address is C/o Urogen Pharma Ltd. 9 Ha'Ta'Asiya Street Ra'Anana L3 4365007 Israel
Urogen Pharma Ltd Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Elizabeth Barrett | 2020 | $636,987 | $0 | $441,150 | $876,164 | $468,650 | $43,716 | $2,466,667 |
| Elizabeth Barrett | 2019 | $694,697 | $300,000 | $15,082,782 | $8,979,216 | $840,000 | $4,128 | $25,900,823 |
| Molly Henderson | 2020 | $94,269 | $100,000 | $294,900 | $787,994 | $69,875 | $15,192 | $1,362,230 |
| Peter P. Pfreundschuh | 2020 | $324,329 | $0 | $176,460 | $292,055 | $218,800 | $152,313 | $1,163,956 |
| Peter P. Pfreundschuh | 2019 | $435,625 | $0 | $212,500 | $436,108 | $261,375 | $1,183 | $1,346,791 |
| Peter P. Pfreundschuh | 2018 | $156,424 | $0 | $527,875 | $1,704,505 | $96,800 | $197 | $2,485,800 |
| Stephen L. Mullennix | 2020 | $139,311 | $0 | $88,230 | $292,055 | $140,200 | $246,581 | $906,376 |
| Stephen L. Mullennix | 2019 | $435,625 | $0 | $212,500 | $436,108 | $261,375 | $904 | $1,346,512 |
| Stephen L. Mullennix | 2018 | $359,754 | $70,000 | $1,102,893 | $2,552,946 | $223,400 | $575 | $4,309,568 |
| Mark Schoenberg | 2020 | $185,026 | $0 | $176,460 | $292,054 | $293150 | $1,767 | $948,458 |
| Mark Schoenberg | 2019 | $205,000 | $0 | $106,250 | $218,054 | $270,000 | $1,604 | $800,908 |
| Mark Schoenberg | 2018 | $200,000 | $0 | $0 | $0 | $100,000 | $0 | $300,000 |
| Jason Smith | 2020 | $126,930 | $100,000 | $491,500 | $785,242 | $92,083 | $19,518 | $1,615,274 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1668243/000156459021021330/urgn-def14a_20210607.htm
What are Urogen Pharma Ltd's Past Insider Trades?
Urogen Pharma Ltd's most recent insider trade came on February 2, 2023 by Jason D. Smith Attorney-In-Fact who sold 1,636 units worth $16.56K . In the last 6 years, insiders at Urogen Pharma Ltd have sold an estimated value of $9.79M and bought an estimated value of $3.31M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Mark Schoenberg, Chief Medical Officer, Elizabeth Barrett, Chief Executive Officer, and Peter Pfreundschuh, Chief Financial Officer .
UroGen Pharma Ltd. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||